Skip to content
Riskpilot
← Back to search
Sign in
Get full access
OxyPharma AB
AB
Active
Org 5566089958
Drottninggatan 29, 111 51
Stockholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2001 · 25 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
OxyPharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−11
−15
−14
−19
−17
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−11
−15
−14
−19
−17
Net financials
3 282
−9 626
−4 761
−2 156
−1 214
Profit before tax
3 271
−4 802
−2 384
−1 097
−624
Tax
−0
−0
−0
−0
−0
Net profit
3 271
−4 802
−2 384
−1 097
−624
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
8 379
3 577
1 193
802
172
Equity
8 371
3 569
1 185
788
164
Long-term debt
0
0
0
0
0
Short-term debt
8
8
8
14
8
Total debt
8
8
8
14
8
Financial ratios
5-year trend
EBITDA margin
-1700000.0%
This company
15.8%
Market median
10759594% below market
2020
2024
Equity ratio
95.3%
This company
38.2%
Market median
149% above market
2020
2024
Return on equity
-380.5%
This company
18.4%
Market median
2168% below market
2020
2024
Net profit margin
-62400000.0%
This company
8.1%
Market median
770370470% below market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
100% below market
2020
2024
Debt / equity
0.05×
This company
0.62×
Market median
92% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on OxyPharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
